Related Experiment Video
Updated: Jun 5, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation
Jessica Castro1, Marc Ribó, Susanna Navarro
1Laboratori d'Enginyeria de Proteïnes, Departament de Biologia, Facultat de Ciències, Universitat de Girona, Campus de Montilivi s/n E-17071 Girona, Spain.
Background:
Ribonucleases are promising agents for use in anticancer therapy. Among the different ribonucleases described to be cytotoxic, a paradigmatic example is onconase which manifests cytotoxic and cytostatic effects, presents synergism with several kinds of anticancer drugs and is currently in phase II/III of its clinical trial as an anticancer drug against different types of cancer. The mechanism of cytotoxicity of PE5, a variant of human pancreatic ribonuclease carrying a nuclear localization signal, has been investigated and compared to that of onconase.
Methods:
Cytotoxicity was measured by the MTT method and by the tripan blue exclusion assay. Apoptosis was assessed by flow cytometry, caspase enzymatic detection and confocal microscopy. Cell cycle phase analysis was performed by flow cytometry. The expression of different proteins was analyzed by western blot.
Results:
We show that the cytotoxicity of PE5 is produced through apoptosis, that it does not require the proapoptotic activity of p53 and is not prevented by the multiple drug resistance phenotype. We also show that PE5 and onconase induce cell death at the same extent although the latter is also able to arrest the cell growth. We have compared the cytotoxic effects of both ribonucleases in the NCI/ADR-RES cell line by measuring their effects on the cell cycle, on the activation of different caspases and on the expression of different apoptosis- and cell cycle-related proteins. PE5 increases the number of cells in S and G2/M cell cycle phases, which is accompanied by the increased expression of cyclin E and p21WAF1/CIP1 together with the underphosphorylation of p46 forms of JNK. Citotoxicity of onconase in this cell line does not alter the cell cycle phase distribution and it is accompanied by a decreased expression of XIAP CONCLUSIONS: We conclude that PE5 kills the cells through apoptosis associated with the p21WAF1/CIP1 induction and the inactivation of JNK. This mechanism is significantly different from that found for onconase.
Insights
PE5, a ribonuclease variant, induces cancer cell death via apoptosis, independent of p53 and drug resistance. Its mechanism differs from onconase, involving cell cycle arrest and JNK inactivation.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ribonucleases are investigated as anticancer agents.
- Onconase, a ribonuclease, shows cytotoxic and cytostatic effects and is in clinical trials.
- PE5, a human pancreatic ribonuclease variant with a nuclear localization signal, is studied for its anticancer potential.
Purpose of the Study:
- To investigate and compare the cytotoxicity mechanisms of PE5 and onconase.
- To elucidate the role of apoptosis, cell cycle, and specific protein pathways in PE5-induced cell death.
Main Methods:
- Cytotoxicity assessed using MTT and trypan blue exclusion assays.
- Apoptosis evaluated via flow cytometry, caspase activity detection, and confocal microscopy.
- Cell cycle distribution and protein expression (cyclins, caspases, XIAP, JNK) analyzed by flow cytometry and western blot.
Main Results:
- PE5 induces apoptosis independently of p53 and multidrug resistance.
- Both PE5 and onconase exhibit similar cell death extent, but only onconase causes growth arrest.
- PE5 treatment increases cells in S and G2/M phases, upregulates cyclin E and p21WAF1/CIP1, and inactivates JNK.
- Onconase does not alter cell cycle distribution but decreases XIAP expression.
Conclusions:
- PE5 mediates cancer cell death through apoptosis, p21WAF1/CIP1 induction, and JNK inactivation.
- The cytotoxic mechanism of PE5 is distinct from that of onconase.
- PE5 represents a promising anticancer agent with a unique mechanism of action.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway
Negative Regulator Molecules
Experimental RNAi
Caspases

